glp 1 receptor agonists names List America's Poison Centers - GLP-1

Omid Mehrpour (MD, FACMT) is a senior medical toxicologist and physician-scientist with over 15 years of clinical and academic experience in emergency medicine and toxicology

Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity

Gastrointestinal side effects may still occur even at reduced doses

[DOI] [PubMed] [Google Scholar] 65.Trumper A, Trumper K, Horsch D

Gastrointestinal effects Every GLP-1 based medication shares a core set of gastrointestinal side effects because they stem from the mechanism of action itself, slowing gastric emptying and altering gut motility

Prior glucose-lowering medication use and 30-day outcomes among 64,892 veterans with diabetes and COVID-19